Access to anti-retroviral drugs, male (%) in Belize
Belize: Access to anti-retroviral drugs, male (%) was 48.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Belize, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Belize recorded 48.0% for access to anti-retroviral drugs, male in 2024. That is the highest value across all 25 years on record.
The figure is up 6.7% on the previous year and up 65.5% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Belize peaked at 48.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Belize 120th out of 141 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male (%) in Belize, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 2.0% | — |
| 2003 | 7.0% | +250.0% |
| 2004 | 7.0% | +0.0% |
| 2005 | 11.0% | +57.1% |
| 2006 | 13.0% | +18.2% |
| 2007 | 13.0% | +0.0% |
| 2008 | 16.0% | +23.1% |
| 2009 | 20.0% | +25.0% |
| 2010 | 22.0% | +10.0% |
| 2011 | 24.0% | +9.1% |
| 2012 | 27.0% | +12.5% |
| 2013 | 30.0% | +11.1% |
| 2014 | 29.0% | -3.3% |
| 2015 | 32.0% | +10.3% |
| 2016 | 34.0% | +6.2% |
| 2017 | 34.0% | +0.0% |
| 2018 | 38.0% | +11.8% |
| 2019 | 38.0% | +0.0% |
| 2020 | 38.0% | +0.0% |
| 2021 | 39.0% | +2.6% |
| 2022 | 41.0% | +5.1% |
| 2023 | 45.0% | +9.8% |
| 2024 | 48.0% | +6.7% |
Belize compared with similar countries
- Belize's 48.0% is below the median for upper middle income countries, which is 65.0%, 74% of the median. (39 countries reporting)
- Belize's 48.0% is below the median for Latin America & Caribbean, which is 67.0%, 72% of the median. (23 countries reporting)
Biggest year-on-year movements
Years where Access to anti-retroviral drugs, male (%) in Belize changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2003 | +250.0% | 2.0% | 7.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 8.9% | 0.0% | 20.0% | 10 |
| 2010s | 30.8% | 22.0% | 38.0% | 10 |
| 2020s | 42.2% | 38.0% | 48.0% | 5 |
Countries ranked near Belize
More gender data for Belize
- Child population (UN estimates and projections) 110.84 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.4356 % change on previous year (2030)
- Population 339 (2030)
- Working-age population (UN estimates and projections) 339 (2030)
- Population (UN estimates and projections), annual growth rate 1.66 % change on previous year (2030)
- Age population, age 00, female, interpolated 3,647 (2025)
- Age population, age 00, male, interpolated 3,832 (2025)
- Age population, age 01, female, interpolated 3,619 (2025)
- Age population, age 01, male, interpolated 3,802 (2025)
- Age population, age 02, female, interpolated 3,506 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Belize?
- Access to anti-retroviral drugs, male in Belize was 48.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Belize?
- The highest recorded value was 48.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Belize?
- The lowest recorded value was 0.0% in 2000.
- How does Belize rank for access to anti-retroviral drugs, male?
- Belize ranks 120th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Belize?
- Over the last ten years it is up 65.5%. The long-run trend across the full record is volatile.
- Where does this Belize data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.